Stay updated on Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial
Sign up to get notified when there's something new on the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page.
Latest updates to the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe website has been updated to version 2.10.3 on August 28, 2024, following the removal of version 2.10.2 on July 3, 2024.SummaryDifference1.0%
- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements in the latest release.SummaryDifference0.3%
- Check50 days agoChange DetectedThe website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.SummaryDifference6%
- Check57 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.3%
- Check68 days agoChange DetectedThe website has been updated with new information as of July 3, 2024, while content from July 2, 2024, has been removed.SummaryDifference0.3%
- Check70 days agoChange DetectedThe value on the webpage has been updated from 2023-11-13 to 2024-07-02, indicating a recent change in the study details or status.SummaryDifference1.0%
Stay in the know with updates to Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page.